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Circulating nitrate (NO3
), derived from dietary sources or endogenous nitric oxide production, is
extracted from blood by the salivary glands, accumulates in saliva, and is then reduced to nitrite (NO2
)
by the oral microﬂora. This process has historically been viewed as harmful, because nitrite can
promote formation of potentially carcinogenic N-nitrosamines. More recent research, however,
suggests that nitrite can also serve as a precursor for systemic generation of vasodilatory nitric oxide,
and exogenous administration of nitrate reduces blood pressure in humans. However, whether oral
nitrate-reducing bacteria participate in ‘‘setting’’ blood pressure is unknown. We investigated whether
suppression of the oral microﬂora affects systemic nitrite levels and hence blood pressure in healthy
individuals. We measured blood pressure (clinic, home, and 24-h ambulatory) in 19 healthy volunteers
during an initial 7-day control period followed by a 7-day treatment period with a chlorhexidine-based
antiseptic mouthwash. Oral nitrate-reducing capacity and nitrite levels were measured after each study
period. Antiseptic mouthwash treatment reduced oral nitrite production by 90% (p o 0.001) and
plasma nitrite levels by 25% (p ¼ 0.001) compared to the control period. Systolic and diastolic blood
pressure increased by 2–3 .5 mm Hg, increases correlated to a decrease in circulating nitrite
concentrations (r2 ¼ 0.56, p ¼ 0.002). The blood pressure effect appeared within 1 day of disruption
of the oral microﬂora and was sustained during the 7-day mouthwash intervention. These results
suggest that the recycling of endogenous nitrate by oral bacteria plays an important role in
determination of plasma nitrite levels and thereby in the physiological control of blood pressure.
& 2012 Elsevier Inc. Open access under CC BY-NC-ND license.The metabolic activity of oral bacteria has traditionally been
associated with negative health effects ranging from halitosis and
caries to more serious conditions such as periodontitis [1] and
even cardiovascular disease [2,3]. This negative view is clearly
reﬂected in the widespread use (30–45% of adults in the UK and
USA) of antiseptic mouthwashes in the general population [4–6].
The conversion of dietary-derived inorganic nitrate (NO3
) to
nitrite (NO2
) by oral bacteria [7] is a classical example of a
proposed harmful process because salivary nitrite, when swal-
lowed, can give rise to N-nitrosamines with potentially carcino-
genic effects [8,9]. This has led to strict regulations of permissible
levels of nitrate in food and drinking water. However, over the
past decade the view of nitrate and nitrite as being only harmful
has slowly started to shift.
A long-since established view has been that both nitrite and
nitrate are generated endogenously as oxidation products of nitric
oxide (NO) metabolism [10,11]: observations that underlie the3
alia).
Y-NC-ND license.dogma that these anions simply represent inert metabolites.
However, more recent ﬁndings demonstrating signiﬁcant vasodi-
lator activity for nitrite in both isolated rat blood vessel studies
[12] and consequently in healthy volunteers [13] have stimulated
a reappraisal of the dogma. We now know that both nitrate and
nitrite can be recycled back to NO under certain scenarios
(particularly being favored by a hypoxic and/or acidic environ-
ment), thereby identifying a potential alternative to the L-argi-
nine/NO synthase pathway for the in vivo generation of NO
[14,15]. In support of the existence of a nitrate–nitrite–NO path-
way, studies have demonstrated that inorganic nitrate or nitrite
supplementation through either parenteral or oral administration
exert functional effects that mimic NO bioactivity beyond vaso-
dilatation [13,16,17], including protection against ischemia/reper-
fusion injury in animal models [18–21], improved mitochondrial
function [22], and blood pressure (BP) reduction in humans
[16,23–25].
The bioactivation of inorganic nitrate requires the formation of
nitrite as an intermediate; a reaction that is facilitated by oral
bacteria [26–29]. Ingested nitrate is rapidly absorbed and accu-
mulates selectively in saliva [7,8,30] via active transport from
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cavity is swallowed and is consequently associated with eleva-
tions of circulating nitrite levels [24,25,32,33]. Exactly how
nitrite, as a charged anion, might cross the gut wall into the
circulation is unknown, although there have been suggestions
that at least in erythrocytes the anion-exchange transporter-1
might have a role to play [34,35]. Alternatively, nitrite may be
absorbed in the form of uncharged HNO2 after protonation in the
acidic stomach. Nevertheless, several different groups have
demonstrated that after elevation of nitrite levels within the
blood and tissues, this nitrite can then undergo further reduction
to NO and other bioactive nitrogen oxides, a reaction facilitated
by one or more possible enzymatic and nonenzymatic pathways
(for review see [36,37]). Because it is now evident that oral
bacteria are crucial in the initial step of a nitrate–nitrite–NO
pathway, it is important to clarify their role in physiological
processes related to NO bioactivity. In this study we investigated
whether reduction of endogenously generated nitrate to nitrite by
oral bacteria under basal conditions (i.e., without exogenous
provision of inorganic nitrate) contributes to circulating nitrite
levels and BP regulation in healthy subjects. For this, we used an
antiseptic mouthwash to disrupt oral nitrate reduction and
measured plasma nitrite concentration and BP over a 1-week
observation period.Methods
Volunteers
The studies were peer reviewed by the institutional review
board and were granted full ethics approval by the Local Research
Ethics Committee. Informed, written consent was taken after
satisfying the inclusion criteria of 18–45 years of age, body mass
index of 18–40 kg/m2, no systemic medication (other than the
oral contraceptive pill), nonsmoker, no self-reported use of
mouthwash or tongue scrapes, no recent or current antibiotic
use (within 3 months), and no history, or recent treatment, of
(within past 3 months) any oral condition (excluding caries),
including gingivitis, periodontitis, and halitosis. Volunteers were
recruited with stratiﬁcation for sex according to the power
calculation performed before the start of the study.
Study design
A crossover study was performed in 19 healthy nonsmoking
volunteers, who reported no prior oral mouthwash use. For all clinic
visits individuals were requested to arrive fasted for 12 h and having
adhered to a low-nitrate diet for the previous 24 h to study the
effect of endogenously derived nitrate only. To support volunteers in
adherence to this request a dietary sheet identifying low-nitrate
foods and options for low-nitrate-containing meals was provided.
For each volunteer repeat visits were scheduled at the same time of
day as the ﬁrst visit. Measurements were taken on each visit in the
same order of clinic BP measurement, followed by collection of
blood, urine, and whole saliva samples. Oral nitrate reduction
capacity was examined (see below) and then a 24-h ambulatory
BP monitor (ABPM) attached, to be returned the following day.
At the end of the ﬁrst visit volunteers were then instructed to
measure their own BP on a daily basis, at the same time each day,
while at home (home BP), for 1 week. Volunteers were instructed to
make no other changes to their lifestyle or diet and to record their
daily nutritional intake using self-reported dietary diaries. On day
7 after measurement of their home BP reading, volunteers
were instructed to rinse their oral cavities with 10 ml Corsodyl
(0.2% chlorhexidine, GlaxoSmithKline, UK) antiseptic mouthwashtwice daily [38] and to continue monitoring home BP on a daily
basis for a further 1 week.
After this entire 2-week period of home BPmonitoring, volunteers
returned for a repeat assessment of clinic BPmeasurement and blood,
urine, and whole saliva sample collection and oral nitrate reduc-
tion. A further 24-h ABPM was attached and returned the
following day. The volunteers were unaware of the hypothesis
of the study.BP measurements
Clinic BP
BP was measured using an Omron 715IT (Omron Corp., Tokyo,
Japan) according to British Hypertension Society guidelines [39].
Seated BP readings were taken in triplicate every 15 min for 1 h
using a validated semiautomated oscillometric machine (Omron
715IT; Omron Corp.). The second and third readings at each time
point were averaged to determine mean clinic BP and heart rate
(HR) and then these readings over the 1-h period were averaged
to provide a clinic BP and HR reading. Both the operator and the
volunteer were blind to these measurements.Home BP
Volunteers were instructed during screening on the correct
use of the Omron 715IT machine and were provided with a
machine and appropriately sized cuff to perform home measure-
ments in triplicate at the same time daily. The second and third
readings at each time point were averaged to determine the daily
mean home BP and HR.ABPM
Twenty-four-hour ABPM was performed using a Spacelabs
90207 machine (Spacelabs Healthcare Ltd., Issaquah, WA, USA).
The following protocol for measurements was used: 0700–2300
hours—one reading every 20 min; 2300–0700 hours—one reading
every 1 h. Proprietary software was used to download readings and
produce 24-h, daytime (0700–2300 hours) and nighttime (2300–
0700 hours) mean BP and HR readings (90256 ABP Report Manage-
ment System; Spacelabs Healthcare).Blood sampling
Blood samples were taken directly after clinic BP measurement
via standard venipuncture into prechilled lithium–heparin Vacu-
tainers as previously described [24]. Plasma was separated and
deproteinated by ﬁltration (centrifugation 14,000 g, 4 1C, 60 min)
using Vivaspin 500, 3-kDa ﬁlters (Sartorius Biotech, Aubagne,
France) and the ﬁltrate stored at 80 1C until analysis by ozone
chemiluminescence. In addition, we determined the levels of
nitrate and nitrite contamination as a consequence of use of the
commercially available blood tubes and ascertained a nitrite
contamination of 102.0710.3 nmol/L and nitrate contamination
of 1.770.1 mmol/L (n ¼ 20 tubes). These levels of contamination
were subtracted from all plasma measures of nitrite and nitrate
concentration, respectively.Urine sampling
Midstream urine samples were collected into sterile contain-
ers and an aliquot was stored at 80 1C until analysis at a later
date for assessment of nitrate and nitrite concentration by ozone
chemiluminescence.
Table 1
Baseline characteristics.
Baseline characteristic
Subjects (n) 19
Age (years) 23.870.5
Body mass index (kg/m2) 23.070.6
Clinic SBP (mm Hg) 110.471.8
Clinic DBP (mm Hg) 66.271.6
Home SBP (mm Hg) 115.371.7
Home DBP (mm Hg) 67.371.1
Ambulatory SBP (mm Hg) 119.271.6
Ambulatory DBP (mm Hg) 70.371.3
Plasma nitrate (mmol/L) 26.772.4
Plasma nitrite (nmol/L) 284.2716.9
Salivary nitrate (mmol/L) 441.8768.6
Salivary nitrite (mmol/L) 316.1730.7
Urinary nitrate (mmol/L) 1462.0764.9
Urinary nitrite (nmol/L) 203.178.8
Baseline anthropometric and hemodynamic char-
acteristics and baseline plasma, urinary, and sali-
vary [nitrate]/[nitrite]. Data are expressed as
means 7 SEM.
Table 2
Self-reported daily dietary intake.
Food group Mean portions/day Signiﬁcance (p)
Baseline Post-mouthwash
Fruit 0.570.2 0.570.2 0.205
Low-nitrate vegetables 0.670.1 0.670.1 0.928
High-nitrate vegetables 0.270.1 0.270.1 0.245
Processed meat 0.770.1 0.770.1 0.793
Self-reported daily dietary intake of speciﬁc food groups in the 7-day study
periods. Data are expressed as means 7 SEM (n ¼ 19). Signiﬁcance shown in last
column for paired Student’s t test.
V. Kapil et al. / Free Radical Biology and Medicine 55 (2013) 93–100 95Saliva sampling
Unstimulated, whole saliva samples were collected into
sterile Eppendorfs and stored at 80 1C until analysis at a later
date for assessment of nitrate and nitrite concentration by ozone
chemiluminescence.
Oral nitrate-reducing capacity
Volunteers were instructed to hold 10 ml of nitrate- and
nitrite-free water for 5 min in the oral cavity after which time
the mouth rinse was collected into sterile ice-chilled Falcon tubes
and centrifuged (5500 g, 4 1C, 10 min) and the supernatants were
collected and stored at 80 1C until nitrite and nitrate determi-
nation by ozone chemiluminescence. After this, matched volumes
of potassium nitrate (Martindale Pharmaceuticals, Ipswich, UK)
solutions of 800 mmol/L (delivering 0.8 mmol in total), reﬂecting
approximate near-physiological salivary nitrate levels, and
8 mmol/L (delivering 80 mmol in total), reﬂecting a 10-fold higher
salivary nitrate level that corresponds to levels achieved after a
nitrate-rich meal, were held in the oral cavity for 5 min in a
randomized order. The mouth rinses were collected and stored
as above.
Ozone chemiluminescence
Levels of nitrate and nitrite in deproteinated plasma and in
urine and saliva samples were measured using ozone chemilu-
minescence as previously described [10]. Because all plasma
samples were ﬁltered using 3-kDa cutoff ﬁlters any potential
other NO adducts that might interfere with the assessment of
nitrite concentrations were absent for analysis. In brief, total
nitrate and nitrite concentration (termed ‘‘NOx’’) was determined
by adding samples to 0.1 mol/L vanadium(III) chloride in 1 M
hydrochloric acid reﬂuxing at 95 1C under nitrogen. Nitrite con-
centration was determined by addition of samples to 0.09 mol/L
potassium iodide in glacial acetic acid under nitrogen at room
temperature. Nitrate concentration was calculated by subtraction
of [nitrite] from [NOx]. All measurements of all samples were
conducted by an individual blinded to the intervention.
Statistical analysis
All data are expressed as means 7 SEM, unless otherwise
speciﬁed, and all statistical analyses were performed using
GraphPad Prism software version 5. For comparison of before
and after BP measurements; salivary, urinary, and plasma nitrite
and nitrate concentrations; and food group intake, paired Student’s
t tests were used. For oral nitrate reduction and repeated daily
home BP measurements the data were analyzed by repeated-
measures two-way ANOVA. Correlations between plasma nitrite
concentration and BP were determined using Pearson’s correlation
coefﬁcient analysis. The level for statistical signiﬁcance was taken
as a¼0.05 for all analyses.Results
The baseline demographic details are shown in Table 1. All
subjects recorded their dietary habits during the two study
periods. Examination of these data revealed no major variations
in diet during the study periods. Estimated daily portion intake of
fruit, high-nitrate-containing vegetables, low-nitrate-containing
vegetables, and processed meat were determined from dietary
diaries and did not differ between the two study periods (Table 2).
Importantly baseline plasma nitrite concentration in theseindividuals was correlated with salivary nitrite levels (Supple-
mentary Fig. S1A).
Effects of an antiseptic mouthwash on nitrite levels in saliva and
plasma and oral nitrate-reducing capacity
After 7 days of use of a twice-daily antiseptic mouthwash salivary,
plasma, and urinary nitrite levels were signiﬁcantly attenuated
(Figs. 1A–C ). Salivary nitrite concentration was reduced by 90%
(D 282 7 35 mmol/L, p o 0.001) and plasma nitrite concentration by
25% (D 71715 nmol/L, p ¼ 0.001). In contrast, salivary, plasma,
and urinary nitrate concentrations were signiﬁcantly elevated after
mouthwash treatment compared to baseline levels (Figs. 2A–C ).
Before mouthwash treatment oral nitrate-reducing capacity
was found to be dose-dependent (Fig. 3), with a calculated
maximal rate of reduction after administration of 0.8 mmol of
KNO3 of 119719 nmol/min and after 80 mmol 221723 nmol/
min. After mouthwash, oral nitrate-reducing capacity was nearly
abolished (90% reduction, p o 0.001 for both nitrate doses
compared to pretreatment rates, Fig. 3).
Antiseptic mouthwash and BP
Seven days’ use of antiseptic mouthwash caused a rise in clinic
systolic (SBP) and diastolic BP (DBP) (Figs. 1D and 4A) that was
associated with a signiﬁcant decrease in plasma nitrite concentration
(r2 ¼ 0.56, p ¼ 0.002, Fig. 1E), and a similar trend for association
between SBP and salivary nitrite concentration was evident, although
this did not reach statistical signiﬁcance (r2 ¼ 0.203, p ¼ 0.052,
Fig. 1. Effects of a 7-day twice-daily use of antiseptic mouthwash on (A) salivary nitrite concentration, (B) plasma nitrite concentration, (C) urinary nitrite concentration,
(D) clinic systolic blood pressure, and (E) the relationship between plasma nitrite concentration and clinic systolic blood pressure. Statistical signiﬁcance was determined
using paired Student t test for n ¼ 19. Correlations were determined using Pearson’s correlation coefﬁcient determination.
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Fig. 2. Effects of a 7-day, twice-daily use of antiseptic mouthwash on (A) salivary nitrate concentration, (B) plasma nitrate concentration, and (C) urinary nitrate
concentration in healthy volunteers. Statistical signiﬁcance was determined using paired Student t test for n ¼ 19.
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of the method of measurement, i.e., clinic BP (DSBP 3.571.0 mmHg,
p ¼ 0.003; DDBP 2.271.0 mmHg, p ¼ 0.038), home (DSBP 2.9 7
0.4 mmHg, p o 0.001; DDBP 2.0 7 0.5 mmHg, p o 0.001), and
ambulatory (DSBP 2.4 7 0.9 mmHg, p ¼ 0.017; DDBP 2.2 7
0.8 mmHg, p ¼ 0.014l Figs. 4A–4C). There were no changes in HR
as estimated using all three distinct techniques: clinic DHR 2.0 7
1.7 bpm, p ¼ 0.25; home DHR 1.3 7 1.0 bpm, p ¼ 0.18; and
ambulatory DHR 2.0 7 1.4 bpm, p ¼ 0.17 (data not shown).Home BP measurement over the course of the ﬁrst week did
not change signiﬁcantly from day to day (Figs. 4D and E).
However, after initiation of a single day’s use of mouthwash,
both home SBP and home DBP were raised compared to before
mouthwash use (Figs. 4D and 4E).
Separation of ABPM data into daytime and nighttime means
demonstrates that daytime ambulatory SBP and DBP were
increased post-mouthwash (DSBP 2.9 7 0.9 mmHg, p ¼ 0.004,
and DDBP 3.0 7 0.8 mmHg, p ¼ 0.002, respectively, Figs. 5A and B),
V. Kapil et al. / Free Radical Biology and Medicine 55 (2013) 93–100 97whereas mouthwash increased only nighttime SBP (DSBP 2.2
7 0.9, p ¼ 0.022) and not DBP (Figs. 5C and D).Discussion
The colonization by micro-organisms of most surfaces of the
human body, including the gut, provides us with a number of
beneﬁcial functions that we do not possess innately. For example,
the symbiotic relationship that humans have with gut microﬂora
endows the host with a number of qualities, not least the capacity
to digest components of plants, host defense, and the develop-
ment of tolerance to a number of pathogens [40]. Whereas a
symbiotic relationship has been demonstrated for a number of
host–microbial interactions in the lower gastrointestinal tract, the
oral microﬂora remains virtually unexplored in this aspect. In fact,
the general view is of an overall detrimental role for this
microﬂora [1–3]. In contrast, our results presented herein support0.00 8.00 80.00
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Fig. 3. Effects of a 7-day, twice-daily use of antiseptic mouthwash on oral nitrate-
reducing capacity. The amount of nitrite in the expelled contents of the oral cavity,
after instillation of 10 ml of 0, 800 mmol/L, or 8 mmol/L KNO3 solution delivering
0, 0.8, or 80 mmol of nitrate, respectively, which was held in the mouth for 5 min,
of healthy volunteers was measured. Data are expressed as means 7 SEM (n ¼
19) and statistical signiﬁcance was determined using repeated-measures two-way
ANOVA followed by Bonferroni posttests.
Fig. 4. Effects of a 7-day, twice-daily use of antiseptic mouthwash on systolic and dias
ambulatory monitoring, and (C) at home and the daily proﬁles of home (D) systolic and
Data are expressed as means 7 SEM (n ¼ 19) and statistical signiﬁcance was determthe notion that oral nitrate-reducing bacteria are beneﬁcial to the
host and participate in the control of cardiovascular NO home-
ostasis to modulate BP.
We have shown that twice-daily use of an antiseptic
mouthwash for 1 week nearly abolished oral conversion of
nitrate to nitrite. More importantly, this was accompanied by a
decrease in plasma nitrite concentration (25%) and a conco-
mitant increase in BP. Furthermore, as evidenced by the home BP
measurements, the persistence of the effect of mouthwash on BP
after the ﬁrst day of instigation suggests that there is no immediate
tachyphylaxis, at least over a 1-week period, in response to the
mouthwash. Our data demonstrating a robust correlation between
changes in plasma nitrite levels and changes in BP support our
contention that prevention of the conversion of nitrate to nitrite by
antiseptic mouthwash underlies the increases in BP. This thesis is
further supported by evidence of the trends toward signiﬁcant
associations between changes in salivary nitrite concentration and
change in SBP, although a prospective study designed to directly
test this relationship is warranted. It is unlikely that these effects
relate to other mechanisms, such as increased stress due to
instillation of mouthwash, because the effects on systolic BP were
present on every occasion throughout the 7-day home BP measure-
ment protocol and also evident in the nighttime SBP.
All volunteers were fasted on clinic visits and had been on a
low-nitrate-containing diet for the preceding 24 h; therefore, the
majority of the circulating nitrate measured in their plasma
originates from the endogenous source of the NO synthase path-
way. The nitrate levels that we measured in our volunteers at
baseline correlate well with previous estimates of the relative
contributions of exogenous vs endogenous nitrate [41]. In light of
this, the present data suggest the existence of a salvage pathway
in which nitrate, derived from oxidized NO, is partly recycled back
to NO with the help of oral nitrate-reducing bacteria. The
signiﬁcant correlation between baseline plasma nitrite levels
and salivary nitrite levels supports the notion of a dependence
of circulating levels of nitrite on the enterosalivary circuit. Our
observations represent the ﬁrst demonstration of the functional
activity of endogenously generated nitrate. Nitrate is a very stable
molecule and, unlike bacteria, mammalian cells cannot efﬁcientlytolic blood pressure in healthy volunteers measured (A) in the clinic, (B) by 24-h
(E) diastolic blood pressure during the 7-day study periods in healthy volunteers.
ined using repeated-measures two-way ANOVA.
Baseline Post Mouthwash
100
110
120
130
140
S
B
P
 (m
m
H
g)
Baseline Post Mouthwash
50
60
70
80
90
100
D
B
P
 (m
m
H
g)
Baseline Post Mouthwash
90
100
110
120
130
140
S
B
P
 (m
m
H
g)
Baseline Post Mouthwash
50
60
70
80
90
100
D
B
P
 (m
m
H
g)
p=0.004 p=0.002
p=0.022 p=0.404
Fig. 5. Effects of a 7-day, twice-daily use of antiseptic mouthwash on 24-h ambulatory blood pressure, separated into daytime (A) systolic and (B) diastolic blood pressure and
nighttime (C) systolic and (D) diastolic blood pressure. Data are expressed as means 7 SEM (n ¼ 19) and statistical signiﬁcance was determined using paired Student t test.
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suggests that the process we describe herein fulﬁlls the criteria
for a true symbiotic relationship whereby the host provides the
oral bacteria with nitrate via active secretion to the site where
they reside. This nitrate is then used by the bacteria as a terminal
electron acceptor to allow respiration in the absence of oxygen. In
return, the bacteria provide the host with nitrite, a substrate used
for further generation of the biological messenger NO [42].
That NO is the likely mediator of the effects seen is supported by
previous observations demonstrating that the BP-reducing effects of
exogenously administered inorganic nitrate are correlated with levels
of the signaling nucleotide cyclic guanosine monophosphate [25],
measurement of which has been recently shown to provide an
‘‘exquisitely’’ sensitive indicator of NO bioactivity [43] and to underlie
many of the beneﬁcial effects of NO.
What is still unclear is exactly how NO-like bioactivity is
obtained from the nitrite formed and where this occurs. A number
of potential pathways for nitrite reduction to NO within the blood
and tissues have been described in preclinical models. However,
to date, conﬁrmation of many of these pathways in humans is
limited. Previous studies in healthy volunteers support a role for
deoxygenated hemoglobin in red blood cells as the mammalian
nitrite reductase [13] and studies with human blood vessels
ex vivo implicate xanthine oxidoreductase [44], although in these
studies the blood vessels used were excess segments
of left internal mammary artery removed for coronary artery
bypass grafting and therefore may represent a pathophysiological
scenario. It is also possible that the effects seen may relate to the
activity of newly formed S-nitrosothiols in blood and tissue:
compounds known to be potent transducers of NO bioactivity
and of particular relevance to vasodilatation [45]. Indeed, inter-
actions between heme-containing proteins, such as hemoglobin,
and nitrite have been shown to promote the formation of
S-nitrosothiols [45]. In this study we did not measure any NO
species other than nitrite and nitrate, as we utilized low-
molecular-weight cutoff ﬁltration to enable speciﬁc estimation
of plasma nitrite levels. However, previous observations have
demonstrated that in healthy volunteers subject to exogenous
oral nitrate treatment there were no measureable changes in
S-nitrosothiol levels, whereas plasma nitrite levels were elevated
four- to ﬁve-fold [32].The increase in BP was reﬂected in all three of the methods
that we employed to accurately measure BP. Indeed, home BP
and 24-h ambulatory BP are being increasingly recognized as
important BP measures for diagnosing and monitoring BP. Although
the increases in BP may seem small (DSBP 2–3 .5 mmHg), it is
estimated each 2 mmHg increase in SBP increases mortality due to
ischemic heart disease and stroke by 7 and 10%, respectively [46].
Our study also suggests that oral nitrate reduction may play an
important role in decreasing cardiovascular disease morbidity
and mortality and intimates possible adverse cardiovascular
effects of antiseptic mouthwash use in healthy individuals. This
may have population-level signiﬁcance, because it is estimated
that 30–45 % of U.K. and U.S. adults regularly use antiseptic
mouthwash [4–6].
This view contrasts with the clear association of periodontal
infection with cardiovascular diseases [2,3] and the vascular
beneﬁts of periodontitis treatment [47], but this may reﬂect
different health status and pathogenic bacterial colonization or
possible translocation of bacteria. Whether a similar pathway
operates in individuals with hypertension or in individuals with
increased risk of developing clinical hypertension (i.e., prehyper-
tension), or indeed whether dysfunction of this pathway might
contribute to cardiovascular disease progression, is unknown,
although recent evidence clearly demonstrates the presence of
nitrate-reducing bacterial species, including Veilonella spp. and
Pseudomonas luteola, in the oral cavity of individuals with athero-
sclerotic disease [48]. However, this possibility will be addressed,
at least in part, by clinical trials that are currently under way to
test whether inorganic nitrate supplementation in hypertensive
populations might lower BP in a way similar to that demonstrated
to occur in healthy individuals.
It is important to appreciate the limitations of this work. In this
study the application of the intervention was not randomized and not
placebo controlled. The former was because of uncertainty regarding
the time taken for the recovery of oral bacterial function after
mouthwash use. However, baseline BP was measured at home daily
for 1 week and remained unchanged throughout this period and the
rise in SBP was evident in nighttime ABPM measurements; this
suggests that the increase in BP after the ﬁrst day of mouthwash use
was not due simply to an order effect. With respect to the second
issue, in this study, we used a particular type of mouthwash that
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a very distinctive taste, complicating development of a ‘‘true’’ placebo.
Further studies utilizing an appropriate placebo control would be of
value. In addition, determination of whether other antiseptic mouth-
wash products would affect nitrite and NO homeostasis in a similar
manner is uncertain. It is also possible that interfering with the oral
bacteria resulted in changes in pathways independent of the nitrate-
reductive pathway that might underlie the changes in BP. However,
given the wealth of data demonstrating that elevations in plasma
nitrite levels through exogenous provision of nitrite, or by supple-
mentation with oral nitrate, are associated with reductions in BP
[13,16,23–25], and the strong correlations evident in this study, it is
likely that the resulting alterations in nitrite levels are responsible for
the physiological results demonstrated herein. Finally our study
included 19 young healthy volunteers based upon power calculations
to determine the n value required to observe signiﬁcant changes in
plasma nitrite concentrations. Clearly larger scale clinical investiga-
tions are warranted to assess the general applicability of our ﬁndings
across the wider population.Conclusions
Our studies provide evidence of a role for oral nitrate-reducing
bacteria in modulation of vascular nitrite and NO homeostasis
and, thereby, a physiological role for nitrite, derived from the oral
reduction of endogenously generated nitrate, in BP regulation.
Our data further suggest that disturbances in nitrite homeostasis
(herein achieved via interruption of nitrate reduction in the oral
cavity by commercial mouthwash use) have small, yet potentially
important, implications for cardiovascular health. Apart from
vasodilator actions, nitrite-derived NO has a number of other
potentially beneﬁcial effects in humans, including inhibition of
platelet aggregation, preservation of endothelial function, and
improvement of mitochondrial efﬁciency [22,24]. Future studies
to evaluate the importance of the enterosalivary circulation of
nitrate to nitrite will reveal if the disturbances in circulating
nitrite homeostasis might affect these processes too, especially in
patient groups at higher overall cardiovascular risk. The recent
discovery, using second-generation sequencing technology, that
subtle regional differences in both species and number of oral
microﬂora exist between populations [49] further support the
possibility that differences in nitrate-reducing oral bacteria may
play an important role in regional differences in physiological
processes, including BP.Author contributions
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